In the News

Nov 23, 2009

Panel Advises on Clinical Pathways: What, Why, and How

Oncology Business Review

By Bryan Cote

Like politics, all cancer care is local. To keep it that way some managed care organizations and community oncology groups are developing pathway programs collaboratively to realign reimbursement incentives and to prepare for the coming wave of expensive, single source biologics set to hit the market in the next five years. At the 2009 Cancer Care Business Summit, a panel of oncology pathway pioneers shared their thoughts during a session titled "Clinical Pathways: What, Why, and How".  Jeff Forringer, President of IntrinsiQ, was a member of the panel.

Click here to read the full article.